689 related articles for article (PubMed ID: 30630459)
21. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
[TBL] [Abstract][Full Text] [Related]
22. The e1a3
Chen Z
Hematology; 2023 Dec; 28(1):2186040. PubMed ID: 36912524
[No Abstract] [Full Text] [Related]
23. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
[TBL] [Abstract][Full Text] [Related]
24. Variant e19a2 BCR-ABL1 fusion transcript in typical chronic myeloid leukemia.
Tutulan-Cunita AC; Chirieac SM; Mocanu G; Luca C; Costache M; Lungeanu A; Arghir A
Clin Lab; 2011; 57(9-10):785-8. PubMed ID: 22029197
[TBL] [Abstract][Full Text] [Related]
25. A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study.
Sadia H; Siddiqui RT; Nasim A
Cancer Genet Cytogenet; 2010 Aug; 201(1):57-61. PubMed ID: 20633771
[TBL] [Abstract][Full Text] [Related]
26. Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
Maiti A; Franquiz MJ; Ravandi F; Cortes JE; Jabbour EJ; Sasaki K; Marx K; Daver NG; Kadia TM; Konopleva MY; Masarova L; Borthakur G; DiNardo CD; Naqvi K; Pierce S; Kantarjian HM; Short NJ
Acta Haematol; 2020; 143(6):567-573. PubMed ID: 32289808
[TBL] [Abstract][Full Text] [Related]
27. The impact of BCR-ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia.
Ercaliskan A; Eskazan AE
Cancer; 2018 Oct; 124(19):3806-3818. PubMed ID: 29694669
[TBL] [Abstract][Full Text] [Related]
28. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
Duan MH; Li H; Cai H
Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
[TBL] [Abstract][Full Text] [Related]
29. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
Burmeister T; Gröger D; Kühn A; Hoelzer D; Thiel E; Reinhardt R
DNA Repair (Amst); 2011 Nov; 10(11):1131-7. PubMed ID: 21944569
[TBL] [Abstract][Full Text] [Related]
30. Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome.
Reboursiere E; Chantepie S; Gac AC; Reman O
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):28-33. PubMed ID: 25300567
[TBL] [Abstract][Full Text] [Related]
31. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
Moore FR; Yang F; Press RD
Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
[TBL] [Abstract][Full Text] [Related]
32. BCR-ABL1 transcript types showed distinct laboratory characteristics in patients with chronic myeloid leukemia.
Vasconcelos AP; Azevedo IF; Melo FCBC; Neves WB; Azevedo ACAC; Melo RAM
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28437552
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
Rosenberg MW; Savage SL; Eide CA; Reister Schultz A; Cook RJ; Press RD; Rempfer C; Eickelberg G; Wilmot B; McWeeney SK; Tyner JW; Druker BJ; Tognon CE
Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307214
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
[TBL] [Abstract][Full Text] [Related]
35. Does BCR/ABL1 positive acute myeloid leukaemia exist?
Nacheva EP; Grace CD; Brazma D; Gancheva K; Howard-Reeves J; Rai L; Gale RE; Linch DC; Hills RK; Russell N; Burnett AK; Kottaridis PD
Br J Haematol; 2013 May; 161(4):541-50. PubMed ID: 23521501
[TBL] [Abstract][Full Text] [Related]
36. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
[TBL] [Abstract][Full Text] [Related]
37. How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.
Hu LH; Pu LF; Yang DD; Zhang C; Wang HP; Ding YY; Li MM; Zhai ZM; Xiong S
Oncol Lett; 2017 Nov; 14(5):5619-5623. PubMed ID: 29113191
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.
Xue M; Wang Q; Huo L; Wen L; Yang X; Wu Q; Pan J; Cen J; Ruan C; Wu D; Chen S
Leuk Lymphoma; 2019 Dec; 60(12):3051-3057. PubMed ID: 31258010
[TBL] [Abstract][Full Text] [Related]
39. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
Lee MH; Song A; Li JY
Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
[TBL] [Abstract][Full Text] [Related]
40. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
Liu K; Hu J; Wang X; Li L
J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
